Physician profile
Stephane Rinfret
NPI 1679168470
$71,713.39
in general payments reported to CMS, 2019-2025
22 companies · $2,565 in 2025
The $2,565 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $10K · 2022: $18K · 2023: $30K · 2024: $11K · 2025: $2,565.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $25K · Honoraria: $7,800 · Food and Beverage: $6,896 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,000 · Travel and Lodging: $1,163.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $24,750.00 |
| Honoraria | $7,800.00 |
| Food and Beverage | $6,896.32 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,000.00 |
| Travel and Lodging | $1,163.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $16,931.24 | 2022-2025 | Turnpike, Guideliner, Manta |
| Arrow International, INC. | $14,908.07 | 2022-2023 | |
| Medtronic, INC. | $13,321.00 | 2021-2025 | Onyx Frontier |
| Abiomed | $12,556.48 | 2021-2025 | Impella |
| Boston Scientific Corporation | $7,212.49 | 2021-2025 | Avvigo Guidance System, Rotablator Rotational Atherectomy System Console Kit, Rotapro |
| Shockwave Medical, INC | $1,537.11 | 2021-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Intravascular Lithotripsy (Ivl) System With The Shockwave C2+ Coronary |
| Abbott Laboratories | $1,457.08 | 2022-2025 | Coroflow, Optis |
| Philips North America LLC | $1,304.18 | 2021 | |
| Asahi Intecc USA, INC. | $860.05 | 2021-2025 | Asahi Peripheral Vascular Wires, Peripheral Vascular |
| Edwards Lifesciences Corporation | $345.61 | 2021-2022 | |
| Spectrawave, INC | $262.11 | 2024-2025 | Hypervue Imaging System, Starlight Imaging Catheter |
| Zoll Circulation INC | $205.00 | 2025 | Catheter, Downstream Cartridge, Therox Ds2 Console |
| Teleflex Medical Canada INC. | $171.75 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $144.09 | 2022-2025 | Lifevest |
| Biotronik INC. | $125.86 | 2024-2025 | Nhancer Rx, Orsiro Mission, Trapit |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Chiesi USA, INC. | $107.24 | 2023 | |
| W. L. Gore & Associates, INC. | $89.28 | 2022 | |
| Verge Medical, INC. | $87.53 | 2023 | |
| Opsens INC. | $33.51 | 2022 | |
| Merit Medical Systems INC | $19.82 | 2025 | Prelude Introducers |
| Heartflow, INC. | $17.60 | 2025 | |
| Esperion Therapeutics, INC. | $16.29 | 2025 | Nexletol |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephane Rinfret listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.